Cite

HARVARD Citation

    Nassar, I. et al. (2022). Proposed pathway for therapeutic drug monitoring and dose escalation of vedolizumab. Frontline gastroenterology. 13 (5), pp. 430-435. [Online]. 
  
Back to record